Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for functional profiling of single cells at scale, today announced a significant expansion of its global commercial presence.

Pharmalittle: We’re reading about MorphoSys drug risks, an AstraZeneca admission, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, because that oh-too predictable routine of online

April 29, 2024

Penumbra axes virtual reality division, will lay off 71 people

Dive Brief: Penumbra will lay off 71 people working in its Immersive Healthcare business, according to a California Worker Adjustment and Retraining Notification notice obtained

August 29, 2024

Amgen closes $28B Horizon acquisition a month after FTC battle ended

Amgen has sealed its high-profile $27.8 billion pursuit of Horizon Therapeutics, closing the deal after a lengthy 10-month acquisition process in which the Federal Trade

October 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.